55I LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

55I LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,756	Closed	-$286K	–	152
2019 Q3	$286K	Buy	+3,756	New	+$312K	0.14%	102

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

55I LLC's XBI Position: Q4 2019 in Review

55I LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 3,756 shares — an estimated $286K sold.

55I LLC first reported a position in XBI in Q3 2019 and held it in 1 quarter. The position peaked at $286K in Q3 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

55I LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
55I LLC sold 3,756 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $286K.
55I LLC first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 1 quarter.
55I LLC's State Street SPDR S&P Biotech ETF position peaked at $286K in Q3 2019.
474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on 55I LLC's 13F filing for Q4 2019, filed 14 Jan 2020.